Statins suppress tumor progression mainly by inhibiting cell survival-related signaling cascades, such as the phosphoinositide 3-kinase/protein kinase B (AKT) and mitogen-activated protein kinase/extracellular signal-regulated kinase pathways, thus inducing cell cycle arrest and reducing tumor cell proliferation [10,16,17,18]. Here, AKT1 is linked to neoplasm.